Skip to content
Head to head

Cellebrite vs Microsoft

Side-by-side on the measures that matter, with a plain-English read. Full detail: CLBT · MSFT

Updated 8 minutes ago

1-year performance, rebased to 100

CLBT -40.7%MSFT -3.7%
Microsoft edges it on the scoreable measures. Microsoft has the highest Quant Rating (40); Microsoft has done best over the past year (+2%); Microsoft trades cheapest on trailing earnings.
CLBTMSFT
Snapshot
SectorSoftware - InfrastructureSoftware - Infrastructure
Last price10.77484.52
Change today-4.86%-2.77%
1-year return-38.2%+1.9%
Market cap$2.71B$3.60T
52-week range9.58 – 19.39347.87 – 558.07
Valuation
P/E (TTM)43.0825.30
P/E percentile, own 5-yr range82nd21st
P/B4.677.65
Dividend yield0.00%0.75%
Profitability & growth
EPS (TTM)0.3117.95
Net profit (TTM)$77.92M$133.30B
Revenue (TTM)$537.28M$346.45B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+18.2%+18.8%
Gross margin82.3%67.7%
Operating margin11.9%47.1%
Net margin12.0%41.2%
Free cash flow (TTM)$141.93M$59.96B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership94.8%75.7%
Insider activity (12mo)10 buy / 20 sell30 buy / 17 sell
Short interest (% of float)2.2%0.8%
Analyst consensus100% buy (3)94% buy / 6% hold (36)
Analyst price target$15 (+39%)$642 (+32%)
StockVane view
StockVane Quant RatingE (10)C (40)
Company
Employees1,285223,000
Founded19991975

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.